A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist

Modern tactics of antihypertensive therapy with fixed dose combination or with free combinations of antihypertensive drugs are reviewed in the article. The evidence that a flexible regimen of combination antihypertensive therapy is more reasonable in the modern treatment of arterial hypertension is...

Full description

Saved in:
Bibliographic Details
Main Authors: S. R. Gilyarevskiy, M. V. Golshmid, G. Yu. Zaharova, I. M. Kuzmina, I. I. Sinitsina
Format: Article
Language:English
Published: Столичная издательская компания 2019-05-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1924
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227644801908736
author S. R. Gilyarevskiy
M. V. Golshmid
G. Yu. Zaharova
I. M. Kuzmina
I. I. Sinitsina
author_facet S. R. Gilyarevskiy
M. V. Golshmid
G. Yu. Zaharova
I. M. Kuzmina
I. I. Sinitsina
author_sort S. R. Gilyarevskiy
collection DOAJ
description Modern tactics of antihypertensive therapy with fixed dose combination or with free combinations of antihypertensive drugs are reviewed in the article. The evidence that a flexible regimen of combination antihypertensive therapy is more reasonable in the modern treatment of arterial hypertension is presented. The question of the characteristics of hypertensive patients in whom lowering blood pressure to lower target levels may be useful to improve the prognosis is discussed considering the results of the analysis of data on participants in a randomized clinical trial SPRINT. Approaches to reducing the incidence of adverse events caused by antihypertensive therapy in such patients in general and in elderly and senile patients who have not only a higher likelihood of achieving advantages of more intensive antihypertensive therapy regimens for influencing the prognosis, but also a higher risk of complications, due to therapy are considered. The problem of less high efficacy of using replicated antihypertensive drugs (generics) compared to the original drugs is discussed.
format Article
id doaj-art-46db3a37c9d24a7d88ce97c0f8ffe159
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2019-05-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-46db3a37c9d24a7d88ce97c0f8ffe1592025-08-23T10:00:31ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532019-05-0115226527010.20996/1819-6446-2019-15-2-265-2701604A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical PharmacologistS. R. Gilyarevskiy0M. V. Golshmid1G. Yu. Zaharova2I. M. Kuzmina3I. I. Sinitsina4Russian Medical Academy of Continuing Professional EducationRussian Medical Academy of Continuing Professional EducationRussian Medical Academy of Continuing Professional EducationSklifosovsky Research Institute of Emergency MedicineRussian Medical Academy of Continuing Professional EducationModern tactics of antihypertensive therapy with fixed dose combination or with free combinations of antihypertensive drugs are reviewed in the article. The evidence that a flexible regimen of combination antihypertensive therapy is more reasonable in the modern treatment of arterial hypertension is presented. The question of the characteristics of hypertensive patients in whom lowering blood pressure to lower target levels may be useful to improve the prognosis is discussed considering the results of the analysis of data on participants in a randomized clinical trial SPRINT. Approaches to reducing the incidence of adverse events caused by antihypertensive therapy in such patients in general and in elderly and senile patients who have not only a higher likelihood of achieving advantages of more intensive antihypertensive therapy regimens for influencing the prognosis, but also a higher risk of complications, due to therapy are considered. The problem of less high efficacy of using replicated antihypertensive drugs (generics) compared to the original drugs is discussed.https://www.rpcardio.online/jour/article/view/1924antihypertensive therapycombined antihypertensive drugsamlodipine
spellingShingle S. R. Gilyarevskiy
M. V. Golshmid
G. Yu. Zaharova
I. M. Kuzmina
I. I. Sinitsina
A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
Рациональная фармакотерапия в кардиологии
antihypertensive therapy
combined antihypertensive drugs
amlodipine
title A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
title_full A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
title_fullStr A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
title_full_unstemmed A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
title_short A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
title_sort flexible regimen of combination antihypertensive therapy for lower blood pressure to the lower target level viewpoint of cardiologist and clinical pharmacologist
topic antihypertensive therapy
combined antihypertensive drugs
amlodipine
url https://www.rpcardio.online/jour/article/view/1924
work_keys_str_mv AT srgilyarevskiy aflexibleregimenofcombinationantihypertensivetherapyforlowerbloodpressuretothelowertargetlevelviewpointofcardiologistandclinicalpharmacologist
AT mvgolshmid aflexibleregimenofcombinationantihypertensivetherapyforlowerbloodpressuretothelowertargetlevelviewpointofcardiologistandclinicalpharmacologist
AT gyuzaharova aflexibleregimenofcombinationantihypertensivetherapyforlowerbloodpressuretothelowertargetlevelviewpointofcardiologistandclinicalpharmacologist
AT imkuzmina aflexibleregimenofcombinationantihypertensivetherapyforlowerbloodpressuretothelowertargetlevelviewpointofcardiologistandclinicalpharmacologist
AT iisinitsina aflexibleregimenofcombinationantihypertensivetherapyforlowerbloodpressuretothelowertargetlevelviewpointofcardiologistandclinicalpharmacologist
AT srgilyarevskiy flexibleregimenofcombinationantihypertensivetherapyforlowerbloodpressuretothelowertargetlevelviewpointofcardiologistandclinicalpharmacologist
AT mvgolshmid flexibleregimenofcombinationantihypertensivetherapyforlowerbloodpressuretothelowertargetlevelviewpointofcardiologistandclinicalpharmacologist
AT gyuzaharova flexibleregimenofcombinationantihypertensivetherapyforlowerbloodpressuretothelowertargetlevelviewpointofcardiologistandclinicalpharmacologist
AT imkuzmina flexibleregimenofcombinationantihypertensivetherapyforlowerbloodpressuretothelowertargetlevelviewpointofcardiologistandclinicalpharmacologist
AT iisinitsina flexibleregimenofcombinationantihypertensivetherapyforlowerbloodpressuretothelowertargetlevelviewpointofcardiologistandclinicalpharmacologist